Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine in Bipolar I Depression
NCT02670551Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Mar 2016
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of cariprazine in bipolar I disorder, sponsored by Forest Laboratories. Started Mar 2016; status: completed.
02
Drugs
cariprazine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT02670551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02670551.